. Author manuscript; available in PMC: 2013 Oct 1.

Published in final edited form as: Kidney Int. 2010 Apr 28;78(3):310–317. doi: 10.1038/ki.2010.131

TABLE 4.

RELATIONSHIP BETWEEN URINE FINDINGS AND IMCD DEPOSITS IN PATIENTS WITH BOWEL DISEASE OR ICSF

	NO IMCD DEPOSITS (15)	APATITE ONLY (11)	APATITE + CAOX (6)	APATITE + UA (5)
SS CAOX	10±1	8±2	10±2	9±2
OX 24^*	41±7	64±8	69±11	32±12
[OX]	0.3±0.1	0.4±0.1	0.5±0.1	0.3±0.1
CA 24^**	231±25	116±29	89±40	169±43
[CA]^**	4.2±0.4	1.7±0.5	1.8±0.7	3.8±0.8
[CA]/[OX]^***	14±1	6±2	3±2	11±2
pH^**	5.84±0.1	5.5±0.1	5.6±0.1	5.3±0.1
SS UA^***	1.2±0.2	1±0.3	1±0.3	3±0.4
SS CAP	1±0.2	0.3±0.2	0.6±0.3	0.6±0.3

Values are ± SEM.

values differ by ANOVA, p<0.05;

^**

p<0.01;

^***

p<0.001;

ICSF, idiopathic calcium stone formers (n=15); [OX], [Ca] oxalate and calcium molarity (mM/l); SS, supersaturation; CaOx, calcium oxalate; CaP, calcium phosphate; UA, uric acid; Ox24 and Ca24, 24 hour urine oxalate and calcium, (mg/d). Bowel patients include all previously reported patients with bypass surgery for obesity (n=5), ileostomy (n=7), and current patients. One small bowel patient with apatite IMCD deposits missing from table (incomplete data).